Noesis Capital Mangement’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
TAM
SI
CPC
Noesis Capital Mangement's NVS Position: Q2 2026 in Review
Noesis Capital Mangement sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,360 shares — an estimated $208K sold.
Noesis Capital Mangement first reported a position in NVS in Q2 2016 and held it in 20 quarters. The position peaked at $345K in Q2 2016. 828 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Noesis Capital Mangement reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Noesis Capital Mangement sold 1,360 Novartis shares in Q2 2026, an estimated $208K.
- Noesis Capital Mangement first reported a position in Novartis in Q2 2016 and held it in 20 quarters.
- Noesis Capital Mangement's Novartis position peaked at $345K in Q2 2016.
- 828 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Noesis Capital Mangement's 13F filing for Q2 2026, filed 4 Aug 2026.